Registers refreshed 2026-11-06.See refresh dates
China

Sequanta Technologies Co.,

240 Hedan Rd, Waigaoqiao Free Trade Zone, Pudong Area, Shanghai, 200131, People's Republic of China, Shanghai, China

Visit website
A2LA 5089.01ISO 15189Register refreshed 2026-11-06

We check which accredited labs can do it, starting with this one, and send you a short comparison of time and rough cost within three working days.

  • Free. No lab gets your details until you choose.
Scope lines
2
A2LA certificate
1
Site in our directory
1
A2LA accredited scope

What this lab is accredited for

We found no published test standard numbers in this lab’s scope. The full scope as published is below.

Only this lab. Searches the method, matrix and range of each of the 2 scope lines.

A2LA certificate 5089.01 · 2 lines

LineMethodMatrixRange
1-Tissue
Show page text

Extracted from the scope document; tables may not line up. View scope for the original.

(A2LA Cert. No. 5089.01) 11/27/2024 Page 1 of 1 SCOPE OF ACCREDITATION TO ISO 15189:2022 SEQUANTA TECHNOLOGIES CO., LTD. 240 Hedan Road Waigaoqiao Free Trade Zone, Pudong Area Shanghai, PEOPLE’S REPUBLIC OF CHINA 200131 Dr. Philip Cotter Phone: 510-332-0477 CLINICAL Valid To: January 31, 2027 Certificate Number: 5089.01 In recognition of the successful completion of the A2LA evaluation process, accreditation is granted to this laboratory to perform the following types of testing on human samples, including Whole Blood (WB), Pathology Tissue, Formalin Fixed Paraffin Embedded (FFPE) block slides, and other bodily fluids/tissues (BF): Specialty Sub Specialty Test/Analyte Method Matrix Pathology Molecular Pathology Foundation One CDx Next Generation Sequencing FFPE Block Slides Foundation One LCDx Next Generation Sequencing WB, BF Pancancer 120 Panel Next Generation Sequencing WB, BF Whole Exome Sequencing Next Generation Sequencing WB, Tissue
-
2

Extracted from the scope document; tables may not line up. View scope for the original.

For the tests to which this accreditation applies, please refer to the laboratory’s Clinical Scope of Accreditation. Accredited Laboratory A2LA has accredited SEQUANTA TECHNOLOGIES CO., LTD. Shanghai, PEOPLE’S REPUBLIC OF CHINA for technical competence in the field of Clinical Testing This laboratory is accredited in accordance with the recognized International Standard ISO 15189:2022 Medical laboratories - Requirements for quality and competence. This accreditation demonstrates technical competence for a defined scope and the operation of a laboratory quality management system (refer to joint IAF-ILAC-ISO Communiqué dated November 2021). Presented this 27th day of November 2024. _______________________ Mr. Trace McInturff, Vice President, Accreditation Services For the Accreditation Council Certificate Number 5089.01 Valid to January 31, 2027

Ranges are reproduced from the accredited scope document as published, and only where we found that range printed in the document for the line. Otherwise the cell reads “See scope document”. An absent range means the register did not state one. Line numbers are ours, for cross-reference; they follow the order of the scope document.

Labs with overlapping accredited scope in China

Accreditation data refreshed from the A2LA register on .

This page mirrors a public register. For a purchasing, audit or regulatory decision, confirm against the A2LA entry linked above.